AMIANNE APRIL HUFFMAN

Physician Assistants & Advanced Practice Nursing Providers|Physician Assistant SAN DIEGO, CA NPI 1144779059

General Payments — all program years on this page

$2,436.48

  • Category: General Payments
  • Program years: PY2021–2024
  • Record count: 118
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $473.94 across 20 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $473.9420

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2021 $604.4531
2022 $481.1625
2023 $876.9342
2024 $473.9420

Records — PY2024 (20)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1086935859 Novartis Pharmaceuticals Corporation $26.39 01/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100482137 Novo Nordisk Inc $23.17 10/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100613735 Novo Nordisk Inc $14.30 02/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1107367521 ABBVIE INC. $24.44 04/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116333979 GlaxoSmithKline, LLC. $22.16 12/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117891651 Boehringer Ingelheim Pharmaceuticals, Inc. $27.12 11/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1130888107 PFIZER INC. $24.51 10/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131075880 PFIZER INC. $27.44 02/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131303186 PFIZER INC. $26.81 03/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131440596 PFIZER INC. $28.84 05/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131490659 PFIZER INC. $20.56 06/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131767676 PFIZER INC. $22.47 07/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135524803 Lilly USA, LLC $31.23 03/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135524805 Lilly USA, LLC $20.56 06/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1137956549 Merz Pharmaceuticals, LLC $43.38 11/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139547785 Astellas Pharma US Inc $20.47 10/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139888792 SANOFI-AVENTIS U.S. LLC $14.93 09/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139888796 SANOFI-AVENTIS U.S. LLC $13.17 10/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1146884076 Philips North America LLC $18.66 09/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1153477158 Salix Pharmaceuticals, a division of Bausch Health US, LLC $23.33 05/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.